The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis

Hepatology

Volumn 32, Issue 5, 2000, Pages 930-934

  Merkel, Carlo ^a   Bolognesi, Massimo ^a   Sacerdoti, David ^a   Bombonato, Giancarlo ^a   Bellini, Barbara ^a   Bighin, Raffaella ^a   Gatta, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE DINITRATE; NADOLOL; NITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMODYNAMICS; HEPATIC VEIN; HUMAN; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRESSURE GRADIENT; PRIORITY JOURNAL; PROPHYLAXIS; REGRESSION ANALYSIS; SCORING SYSTEM; STATISTICAL ANALYSIS; VENOUS PRESSURE;

EID: 0033765377     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.19322     Document Type: Article

References (25)

1. Beta-adrenergic antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors from 589 patients from four randomized clinical trials
2. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis
3. Importance of the 1-month-effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis
4. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis
5. Predictive value of variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension
6. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding
7. Clinical vs. hemodynamic response to drugs in portal hypertension
8. Hemodynamic events in a prospective randomized trial of propranolol vs. placebo in the prevention of the first variceal hemorrhage
9. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
10. Measurement of portal pressure and its clinical application
11. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis
12. Methods to evaluate portal hypertension
13. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis
14. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the β-blocker alone
15. Non-parametric estimation from incomplete observations
16. A generalized Kruskal-Wallis test for comparing k samples subject to unequal pattern of censorship
17. Regression model and life tables
18. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices
19. AISF practice guidelines for portal hypertension
20. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding
21. Long-term effects of beta-adrenergic blockade with nadolol on hepatic and renal hemodynamic and function in cirrhotic patients
22. Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis
23. Copenhagen Study Group for Liver Diseases. Prognostic indicators in alcoholic cirrhotic men
24. Prognostic value of hepatic venous pressure gradient measurement in alcoholic cirrhosis. A 10-year prospective study
25. Hepatic venous pressure measurement: An old test as a new prognostic marker in cirrhosis?